Oncology Institute (DFPH) Receivables - Net (2020 - 2026)

Oncology Institute (DFPH) has reported Receivables - Net for 7 consecutive years, with $58.1 million the latest figure, recorded in Q1 2026.

• Receivables - Net for Q1 2026 came in at $58.1 million, up 17.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.1 million (up 17.87% YoY), and the FY2025 annual result was $59.0 million, up 22.06% from the prior year.
• Receivables - Net was $58.1 million for Q1 2026 at Oncology Institute, down from $59.0 million in the prior quarter.
• Over five years, Receivables - Net peaked at $59.6 million in Q3 2025 and troughed at $24.5 million in Q1 2022.
• Average Receivables - Net over 5 years is $47.6 million, with a median of $48.4 million recorded in 2023.
• Year-over-year, Receivables - Net soared 99.01% in 2022 and decreased 16.07% in 2025.
• Over 5 years, Receivables - Net stood at $39.8 million in 2022, then climbed by 6.39% to $42.4 million in 2023, then gained by 14.11% to $48.3 million in 2024, then increased by 22.06% to $59.0 million in 2025, then dropped by 1.46% to $58.1 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $58.1 million in Q1 2026, $59.0 million in Q4 2025, and $59.6 million in Q3 2025.